Ratnaparkhi M P, Wattamwar M M, Kutmalge M. D, Jadhav A N, Chaudhari S P
Several approaches have been immerged to prolong the residence time of the dosage forms at the absorption site and one of them is the development of oral controlled release mucoadhesive system. Mucoadhesive drug delivery systems are used to enhance drug absorption in a site-specific manner. Bioadhesion has been defined as the attachment of synthetic or biological macromolecules to a biological tissue. The biological surface can be epithelial tissue or the mucous coat on the surface of a tissue. If adhesive attachment is to a mucous coat, the phenomenon is referred to as mucoadhesion. Mucus is a thin blanket covering all epithelia that are in contact with the external environment in the gastrointestinal, respiratory, and urogenital tracts. This approach involves the use of mucoadhesive polymers, which can adhere to the epithelial surface in the stomach. Carrier technology offers an intelligent approach for drug delivery by coupling the drug to a carrier particle such as microspheres, nanospheres, liposomes, nanoparticles, etc., which modulates the release and absorption of the drug. Microspheres constitute an important part of these particulate drug delivery systems by virtue of their small size and efficient carrier capacity.
